Stock Price Quote

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE748.552.45 (+0.33 %)
PREV CLOSE ( ) 746.10
OPEN PRICE ( ) 750.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 137644
TODAY'S LOW / HIGH ( )741.60 752.05
52 WK LOW / HIGH ( )356.75 829
NSE748.452.15 (+0.29 %)
PREV CLOSE( ) 746.30
OPEN PRICE ( ) 748.30
BID PRICE (QTY) 748.45 (2325)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5471533
TODAY'S LOW / HIGH( ) 741.60 752.00
52 WK LOW / HIGH ( )355.3 829.05
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 17-08 1935
Management Info
Y K Hamied - Chairman Umang Vohra - Managing Director
Registered Office

Address Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000 / 022-24826951

Email cosecretary@cipla.com

Website www.cipla.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX

NEWS

18Nov Cipla signs licensing agreement with M
Cipla has signed a licensing agreement with a Belgium-based firm, Multi..
18Nov Cipla gains on signing licensing agree
Cipla is currently trading at Rs. 748.45, up by 5.95 points or 0.80% fro..
18Nov Cipla informs about press release
Cipla has informed that it has enclosed press release dated 18th Novembe..
09Nov Biocon, Aurobindo Pharma and Cyient to
Biocon’s subsidiary company -- Biocon Biologics’ board has approved a Rs..
09Nov Cipla looking at sustaining growth thr
Cipla is looking at sustaining growth through the pandemic and has decid..

Financials

in Millions
QTR Sep 20 ANNUAL 20
Net Profit7456.423181.7
Gross Profit 10176.5 29643.1
Operating Profit 11701.436001.4
Net Sales 38078.9126591.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE)
peergroup  6355.00 (2.04%)
M.Cap ( in Cr)10548.91
Valiant Organics (BSE)
peergroup  3163.80 (3.76%)
M.Cap ( in Cr)4295.41
Abbott India (BSE)
peergroup  15305.70 (0.71%)
M.Cap ( in Cr)32553.40
Sanofi India (BSE)
peergroup  8327.00 (1.16%)
M.Cap ( in Cr)19177.60
Dr. Reddys Lab (BSE)
peergroup  4910.95 (1.71%)
M.Cap ( in Cr)82094.90

Shareholding Pattern

PROMOTERS 36.7%
NON-INSTITUTION 23.48%
FI/BANKS/INSURANCE 2.86%
MUTUAL FUNDS/UTI 16.58%
FII 0.01%
GOVERNMENT 0%

About Cipla Ltd.

Cipla Ltd. was incorporated in the year 1935. Its today's share price is 746.1. Its current market capitalisation stands at Rs 60366.52 Cr. In the latest quarter, company has reported Gross Sales of Rs. 271312.3 Cr and Total Income of Rs.175013.7 Cr. The company's management includes Samina Hamied, Punita Lal, Peter Mugyenyi, Naina Lal Kidwai, Ashok Sinha, Adil Zainulbhai, S Radhakrishnan, Umang Vohra, MK Hamied, Y K Hamied.

It is listed on the BSE with a BSE Code of 500087 , NSE with an NSE Symbol of CIPLA and ISIN of INE059A01026. It's Registered office is at Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower ParelMumbai-400013, Maharashtra. Their Registrars are ACC Ltd. It's auditors are RGN Price & Co, RS Bharucha & Co, V Sankar Aiyar & Co, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)